Nystatin And Triamcinolone Acetonide Cream
NDC Package 70518-1114-0
Package Information
Nystatin And Triamcinolone Acetonide cream is and Ointment are indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment. This formulation utilizes a cream delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-1114 and is authorized under FDA application ANDA062364.
Identification & Billing
- RxCUI: 1053753 - nystatin 100,000 UNT/GM / triamcinolone acetonide 1 MG/GM Topical Cream
- RxCUI: 1053753 - nystatin 100000 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream
- RxCUI: 1053753 - nystatin 100,000 UNT/ML / triamcinolone acetonide 1 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70518 - Remedyrepack Inc.
- 70518-1114 - Nystatin And Triamcinolone Acetonide
- 70518-1114-0 - 1 TUBE in 1 CARTON / 30 g in 1 TUBE
- 70518-1114 - Nystatin And Triamcinolone Acetonide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70518-1114-0 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube of Nystatin And Triamcinolone Acetonide, a human prescription drug labeled by Remedyrepack Inc.. This product is billed per "GM" gram and contains an estimated amount of 30 billable units per package. This cream is formulated for topical use and contains nystatin; triamcinolone acetonide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on April 12, 2018. The current certification is valid through December 31, 2027.
How is this Remedyrepack Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518111400. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.